RxGenesys Biotech is a privately funded virtual biotechnology company based in Miami, Florida with global distribution and licensing rights to a novel MicroRNA Technology for applications in Wound Healing and Cosmetic Formulations. The technology is patented/patent pending in USA, Europe and Asia
Our NewTech development program brings together the most advanced iPS technologies with scientists and formulators as well as skincare, pharmaceutical, biotechnology and medical device industry leaders to develop a new generation of solutions to help skin look younger and heal faster. By working side by side with partners and clients, RxGenesys Biotech aims to make available to the market the benefits of our unique iPS technology through its integration with a wide variety of compounds and devices.
RxGenesys Biotech is currently exploring the development of new products with Wound Healing Device companies and compounding pharmacies